Zacks: Analysts Expect Docebo Inc. (NASDAQ:DCBO) Will Post Quarterly Sales of $31.81 Million

Wall Street brokerages expect Docebo Inc. (NASDAQ:DCBOGet Rating) to post sales of $31.81 million for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Docebo’s earnings. The lowest sales estimate is $31.00 million and the highest is $32.80 million. Docebo posted sales of $21.74 million during the same quarter last year, which indicates a positive year-over-year growth rate of 46.3%. The firm is expected to issue its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Docebo will report full year sales of $146.69 million for the current financial year, with estimates ranging from $141.90 million to $151.10 million. For the next year, analysts expect that the business will report sales of $196.81 million, with estimates ranging from $183.70 million to $208.80 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow Docebo.

Docebo (NASDAQ:DCBOGet Rating) last released its earnings results on Thursday, March 10th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. The company had revenue of $29.80 million during the quarter, compared to the consensus estimate of $29.46 million. The company’s revenue was up 58.5% on a year-over-year basis. During the same period last year, the firm posted ($0.12) EPS.

A number of research firms have commented on DCBO. Morgan Stanley began coverage on Docebo in a research report on Tuesday, April 26th. They set an “equal weight” rating and a $54.00 price target for the company. CIBC decreased their target price on Docebo from C$125.00 to C$102.00 in a research report on Monday, January 10th. Finally, Canaccord Genuity Group decreased their target price on Docebo from $80.00 to $65.00 in a research report on Friday, March 11th. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $86.50.

DCBO opened at $40.37 on Friday. The business has a 50 day simple moving average of $46.97 and a two-hundred day simple moving average of $57.96. The firm has a market capitalization of $1.33 billion, a price-to-earnings ratio of -98.46 and a beta of 2.06. Docebo has a one year low of $38.31 and a one year high of $92.75.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Kaizen Financial Strategies boosted its stake in Docebo by 23.7% during the 1st quarter. Kaizen Financial Strategies now owns 4,700 shares of the company’s stock valued at $244,000 after purchasing an additional 900 shares during the last quarter. Aigen Investment Management LP purchased a new stake in Docebo during the 1st quarter valued at $253,000. Advisor Group Holdings Inc. boosted its stake in Docebo by 75.1% during the 1st quarter. Advisor Group Holdings Inc. now owns 1,805 shares of the company’s stock valued at $709,000 after purchasing an additional 774 shares during the last quarter. Envestnet Asset Management Inc. purchased a new stake in Docebo during the 1st quarter valued at $295,000. Finally, Integrated Advisors Network LLC purchased a new stake in Docebo during the 1st quarter valued at $289,000. Institutional investors and hedge funds own 35.59% of the company’s stock.

Docebo Company Profile (Get Rating)

Docebo Inc provides a cloud-based learning management system to train internal and external workforces, partners, and customers in North America, Europe, and the Asia-Pacific region. Its platform helps customers to centralize learning materials from peer enterprises and learners into one learning management system (LMS) to expedite and enrich the learning process, increase productivity, and grow teams uniformly.

Further Reading

Get a free copy of the Zacks research report on Docebo (DCBO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Docebo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docebo and related companies with MarketBeat.com's FREE daily email newsletter.